Navigation Links
US Cancer Vaccine Market Analysis
Date:9/17/2012

can be expected to come up soon with promising candidates, such as Lucanix and Stimuvax having entered phase 3 trials.

The report also covers the FDA's vaccine approval process and its guidance to the industry for developing therapeutic cancer vaccines. The therapeutic vaccines currently account only for about 15% share in the US cancer vaccine market but this share can be expected to increase drastically post 2016 with such high focus on developing therapeutics for other cancer types.

The report "US Cancer Vaccine Market Analysis", is an outcome of an extensive research and prudent analysis of the cancer vaccine market in the world and in US. It provides an effective analysis of the market drivers, current market size, and future estimates. It also provides the key constraints faced by these cancer vaccine products that can hinder its market growth in the future. Further, the report provides an in-depth analysis on the pipeline cancer vaccines in phase 1-4 clinical stages for most prevalent cancers in US. The regulatory environment detailing the whole cancer vaccine approval process along with FDA's guidelines for clinical proceedings of cancer therapeutic vaccines has also been provided. The report also provides competitive analysis of the promising players in the market along with their key strategies to increase their penetration in the market.

1. Analyst View2. Research Methodology3. Cancer Statistics by Demographics3.1 Prevalence, Incidences and Mortality (2008-2016)3.2 Leading States by Incidence3.3 Leading Cancers by Incidence3.3.1 Male Cancer Incidences3.3.2 Female Cancer Incidences3.3.3 Age-Group4. Cancer Vaccines Market Outlook4.1 Market Analysis and Segmentation4.2 Key Product Analysis4.2.1 Provenge4.2.1.1 Market Analysis4.2.1.2 Restraints4.2.2 HPV Vaccine4.2.2.1 Gardasil4.2.2.1.1 Market Analysis4.2.2.1.2 Restraints4.2.2.2 Cervarix4.2.2.2.1 Market Analysis4.2.2.2.2 Restraints4.2.3 HBV Vaccines4.2.3.1 Market Analysis4.2.3.2 Market Re
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
2. Onconome Announces Results Of Blood Test For Colorectal Cancer; Further Trials Underway
3. Prostate Cancer: The End of Life As Men Know It?
4. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
5. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
6. Frost & Sullivan Lauds IncellDx for Developing a Novel, Non-invasive Method for Cervical Cancer Testing
7. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
8. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. Urologists And Henry Schein Team Up To Urge Families To Put A Prostate Cancer Check-Up On The Back To School List For Dad
10. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
11. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 16, ... invited to listen to the live discussion via the ... at https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay ... the conclusion of the live event and accessible via ...
(Date:8/27/2015)... The nation,s newest Actos trial gets underway Thursday, August 27 ... courtroom.  Attorneys representing two southern Nevada ... after using the diabetes drug Actos. "Takeda Pharmaceuticals ... that their drug Actos caused an increased risk of bladder ... hold Takeda responsible it is appropriate to seek substantial punitive ...
(Date:8/27/2015)...  Mytrus, a technology and services company revolutionizing clinical trials, announced ... has received approval for use by Britain,s ... first time e-Consent technology will be used in a ... Mytrus was also the first electronic informed consent ... the U.S. Food and Drug Administration in 2011. It ...
Breaking Medicine Technology:2 Billion Dollar Verdict Sought In Actos Trial 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7
... , SAN DIEGO, Oct. 26 Horizon Therapeutics, ... an analysis from two pivotal Phase 3 trials ... HZT-501, a combination of ibuprofen with high-dose famotidine. ... risk factors for the development of non-steroidal anti-inflammatory ...
... Volcano Corporation (Nasdaq: VOLC ), a leader in ... and treatment of coronary and peripheral artery disease, today announced ... quarter and first nine months of fiscal 2009 on Thursday, ... to discuss its financial results and operating activities open to ...
Cached Medicine Technology:Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 2Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 3Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 4Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2
(Date:8/27/2015)... ... August 27, 2015 , ... ... , scheduled for October 27-29, 2015 in San Jose, CA. The first ... primarily focus on the void that exists where battery development and energy storage ...
(Date:8/27/2015)... ... 2015 , ... More destinations and stores are becoming pet-friendly, making the family ... sharing some tips to help your whole family travel safely and comfortably. , According ... each year. Amica is sharing the following tips from the American Society for the ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... blending all in one machine with the Nutri Ninja® Auto-iQ Pro Complete and ... Auto-iQ™ Smooth Boost™ Technology that takes drink customization to a whole new level. ...
(Date:8/27/2015)... ... 2015 , ... King Kullen, America’s First Supermarket, is celebrating 85 years of ... 1930 and recognized by the Smithsonian Institute as America’s First Supermarket, King Kullen changed ... Cullen & Kennedy families have created a culture of caring while building their business. ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... development solutions for drugs, biologics and consumer health products, today announced that Ms. ... FlyPharma Conference, to be held at the Radisson Blu Edwardian Hotel, London Heathrow, ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4Health News:King Kullen Honors Their 85 Years of Success this August 2Health News:Clinical Trial Supply Chain Logistics to be Discussed By Catalent Expert at Upcoming Flypharma Conference 2
... Public Health has found that the state level rates of suicide ... ownership of firearm. ,"We found that where there ... Professor of Health Policy and Management at HSPH and lead author ... 15 leading causes of death in the U.S.; among persons less ...
... The Texas Youth Commission’s (TYC) facilities continue to reel under ... News unearthed sordid// details about the agency. , ... physical abuse of the juvenile inmates, as well as gross ... that the inmates have had to wait up to even ...
... sheer torture for your aching back too. If medication ... relief. ,Inserting fine needles into the skin ... and even moderately severe depression. ,"Acupuncture helps ... as migraines and arthrosis, but also stress and asthma," ...
... may no longer be a mantra to stay fit. ... effects// on human lifespan. ,Researchers at the ... into the benefits of commonly used vitamin supplements, including ... ,They found that vitamin supplements appeared to ...
... for head injuries at the Army Hospital at Delhi is ... a road accident in West Bengal on Saturday and is ... ,A team of top-notch specialists reviewed the minister's health in ... ,"He is able to walk around and is progressing ...
... to grips with global warming and climate change, the small ... way ahead. ,Bhutan is set to become the ... a constitutional obligation to preserve the environment, according to the ... from 24 nations of Asia gather in the Bhutanese capital ...
Cached Medicine News:Health News:Household Guns Associated With Higher Rates of Suicide in US 2Health News:Acupuncture Points Way to Relief from Many Ailments 2Health News:Recovering Pranab Mukherjee Likely to Be Discharged Tomorrow 2Health News:Bhutan Leads the World in Preserving the Environment 2
... Medpor Channel Implants, designed to ... the surgeon with an excellent ... wall and floor blowout defects. ... for placement of one or ...
The new Medpor Superior Lateral Orbital Rim is designed for subtle augmentation of the lateral and superior or orbital rims in patients who are hypoplasic in the superior-lateral aspect of the orbita...
The new Medpor Orbital Rim Onlay Implants are designed to support the lower eyelid and lateral canthus in patients who have inadequate support due to congenital variation or changes with aging....
... handle. Divides nucleus for phacoemulsification. Nuclear division ... hardness can be pre-chopped with pre-chop forceps ... fragments is rapid. Risk of rupturing posterior ... sound time and minimal movement of phaco ...
Medicine Products: